- Home
- STRO vs TSSI Comparison
STRO vs TSSI Comparison
Compare STRO & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- TSSI
- Stock Information
- Founded
- STRO 2003
- TSSI 2004
- Country
- STRO United States
- TSSI United States
- Employees
- STRO N/A
- TSSI N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- TSSI Professional Services
- Sector
- STRO Health Care
- TSSI Consumer Discretionary
- Exchange
- STRO Nasdaq
- TSSI Nasdaq
- Market Cap
- STRO 172.8M
- TSSI 166.1M
- IPO Year
- STRO 2018
- TSSI N/A
- Fundamental
- Price
- STRO $2.06
- TSSI $9.69
- Analyst Decision
- STRO Strong Buy
- TSSI
- Analyst Count
- STRO 7
- TSSI 0
- Target Price
- STRO $12.14
- TSSI N/A
- AVG Volume (30 Days)
- STRO 1.4M
- TSSI 1.1M
- Earning Date
- STRO 11-13-2024
- TSSI 01-01-0001
- Dividend Yield
- STRO N/A
- TSSI N/A
- EPS Growth
- STRO N/A
- TSSI N/A
- EPS
- STRO N/A
- TSSI 0.18
- Revenue
- STRO $160,955,000.00
- TSSI $122,527,000.00
- Revenue This Year
- STRO N/A
- TSSI N/A
- Revenue Next Year
- STRO N/A
- TSSI N/A
- P/E Ratio
- STRO N/A
- TSSI $54.76
- Revenue Growth
- STRO 230.90
- TSSI 199.30
- 52 Week Low
- STRO $2.04
- TSSI $0.24
- 52 Week High
- STRO $6.13
- TSSI $12.99
- Technical
- Relative Strength Index (RSI)
- STRO 27.92
- TSSI N/A
- Support Level
- STRO $2.03
- TSSI N/A
- Resistance Level
- STRO $3.01
- TSSI N/A
- Average True Range (ATR)
- STRO 0.18
- TSSI 0.00
- MACD
- STRO -0.04
- TSSI 0.00
- Stochastic Oscillator
- STRO 2.55
- TSSI 0.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: facilities, and systems integration. It generates the majority of its revenue from Systems integration services. It generates revenue from the United States.